Implicaciones de la pandemia en la radioterapia para el cáncer de mama. Radioterapia hipofraccionada

The current pandemic due to the new coronavirus (SARS-CoV-2) has put health systems around the world to the test, in a way so urgent that had not been seen in several years. The implications in health care not only affect patients with COVID-19, but they are transversal to all pathologies. Specifically in breast cancer, hypofractionated radiotherapy schemes constitute a valid and safe alternative that helps reduce the exposure of patients to the new virus, the congestion of health institutions and the costs of specialized cancer treatments. In this article, we conducted a review of the most relevant literature on shortened radiotherapy regimens in breast cancer: hypofractionation and extreme hypofractionation, and their equivalence with fractionation. In the end, the recommendations of different scientific societies and international experts are highlighted, to consider hypofractionated radiotherapy schemes, regarding the global health contingency.